Hepatotoxicity induced by cyproteron acetate in the prostate carcinoma treatment - A case report;Hepatotoxicita po cyproteron acetátu v léčbě karcinomu prostaty - Kazuistika

Klinicka Onkologie

Volumn 26, Issue 1, 2013, Pages 47-48

  Vodička, Martin ^a   Salek T ^b   Roderova E ^c   Cerny D ^d  

^a a s   (Czech Republic)

^b Oddeleni Klinicke Biochemie   (Czech Republic)

^c IPVZ   (Czech Republic)

^d NA HOMOLCE HOSPITAL   (Czech Republic)

Author keywords

Androgen antagonists; Case reports; Cyproterone acetate; Drug toxicity; Drug induced liver injury

Indexed keywords

ATORVASTATIN; CYPROTERONE ACETATE;

AGED; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; DRUG WITHDRAWAL; HUMAN; JAUNDICE; LIVER CELL DAMAGE; LIVER FAILURE; LIVER TOXICITY; PROSTATE ADENOCARCINOMA;

EID: 84874783016     PISSN: 0862495X     EISSN: 18025307     Source Type: Journal    
DOI: 10.14735/amko201347     Document Type: Article

References (5)

1. Savidou I, Deutsch M, Soultati AS et al. Hepatotoxicity induced by cyproterone acetate: a report of three cases. World J Gastroenterol 2006; 12(46): 7551-7555. (Pubitemid 46017759)
2. Manso G, Thole Z, Salgueiro E et al. Spontaneous reporting of hepatotoxicity associated with antiandrogens: data from the Spanish pharmacovigilance system. Pharmacoepidemiol Drug Saf 2006; 15(4): 253-259.
3. .Thole Z, Manso G, Salgueiro E et al. Hepatotoxicity induced by antiandrogens: a review of the literature. Urol Int 2004; 73(4): 289-295. (Pubitemid 39664297)
4. Zimmerman H. Hepatotoxicity the adverse effects of drugs and other chemicals on the liver. Lippincott Williams & Wilkins 1999.
5. Padda MS, Sanchez M, Akhtar AJ et al. Drug-induced cholestasis. Hepatology 2011; 53(4): 1377-1387.